What they were paid
CATALYST PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $81,000 | $300,019 | $0 | $0 | $381,019 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CATALYST PHARMACEUTICALS, INC. DEF 14A filed April 11, 2025, accession 0001193125-25-079097, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024CATALYST PHARMACEUTICALS pays directors a $60,000 cash retainer.
Committees
FY2024 · as the proxy prints themCompensation (Chair) · Nominating/Governance
The rest of the CATALYST PHARMACEUTICALS board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Charles B. O'Keeffe | Director | $408,644 |
| Donald A. Denkhaus | Independent Director | $386,269 |
| Molly Harper | Independent Director | $439,144 |
| Patrick J. McEnany | Chair of the Board | $844,759 |
| Richard J. Daly | Director | $0 |
| Tamar Thompson | Independent Director | $381,019 |
The full CATALYST PHARMACEUTICALS compensation record
free company briefThis page is one director within CATALYST PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat